| Name | Title | Contact Details |
|---|
Patient populations deserve better care. We believe this is possible when physicians are empowered with actionable real-time data to make the most informed medical decisions possible. Alio Medical is medical technology company focused on providing peace of mind to dialysis patients through advanced remote monitoring. Alio provides wireless, remote, noninvasive monitoring of end stage kidney disease (ESKD) patients undergoing hemodialysis. Alio monitors dialysis patient blood flow by capturing and transmitting multimodal sensor data at regular intervals using quantitative analysis of optical, mechanical, acoustic, and thermal data related to blood flow and the composition of the blood itself. Alio remote monitoring utilizes a wearable device, the SmartPatch, placed over the patient`s vascular access graft to gather data and transmit it to a Hub located in the patient`s home. The Hub relays this raw data to the Alio Cloud where it is processed and analyzed utilizing Alio`s proprietary algorithms, developed using data collected pre- and post-dialysis in clinical centers in the US and UK. Alio clinically actionable data is accessed by the clinical team via a web-based data portal and the clinical team is alerted if an abnormality in any of a patient`s metrics is detected. Alio is designed to allow the dialysis patient healthcare team to partner effectively and enjoy simpler care coordination as well as more effective management of their patient`s health.
Prescient Surgical, Inc. is a medical device innovator that makes advanced tools and technologies to fight and defend against the sources of surgical site infection.
Visage imaging is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Ambulatory care at Hotel Dieu Hospital (HDH) is specialized care that may include a scheduled visit to one or more hospital clinics, diagnostic or procedural areas. In some cases, a single health care professional, for example a surgeon or internal medicine physician, may see patients in a traditional clinic setting. Increasingly, patients and families will receive care in a team-based inter-disciplinary and/or inter-professional program, such as our pre-surgical screening, diabetes, breast assessment, bariatric, chronic pain or cardiac rehabilitation programs. Ambulatory care at HDH includes care for patients with urgent and less critical emergency problems at our Urgent Care Centre. Hotel Dieu Hospital has a very active ambulatory surgery program where most patients return home the same day. We also have a short-stay facility in the form of a satellite post-anesthetic care unit that supports patients who need extended time for pain control and rehabilitation therapy. This facility is key to our innovative fast-track total hip and knee arthroplasty program. Hotel Dieu Hospital is a faith-based, academic hospital where research and learning take place every day and where we are committed to partnership with patients and families. We actively engage in implementing innovative models of care that support patient care, as well as regional and academic health care needs. Affiliated with Queen`s University, we serve as a major teaching location for learners from across the Faculty of Health Sciences, including medical, nursing and allied health learners. And research at Hotel Dieu Hospital contributes to the growing field of knowledge about health care and ambulatory care in Canada and beyond. Ambulatory care at Hotel Dieu Hospital is part of an integrated, cost-effective system of health care in Southeastern Ontario.
CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.